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Abstract
Background: Drug misuse is a major problem that has an extreme negative effect on people’s health.
Methamphetamine (MA) is frequently used by young adults, despite its harmful consequences. The Transtheoretical
Model (TTM) has been known to be very effective in explaining both the achievement and cessation of several
health-related behaviors. Therefore, in this study, the TTM was used toward the domain of immoderate MA use
among young adults. This study aimed to test the validity and reliability of a decisional balance scale for MA use in
young adults.
Methods: A multi-phase scale development approach was used to develop the scale. First, 41 university students
enrolled in a qualitative study that generated content for a primary set of a 40-item instrument. In order to produce
a pre-final version of the instrument, face and content validity were calculated in the next step. The instrument
validation was assessed with a sample of 250 university students. Then, the construct validity (exploratory and
confirmatory), convergent validity, discriminate validity, internal consistency applying test-retest reliability, and
Cronbach’s alpha of the scale were measured.
Results: Forty items were initially generated from the qualitative data. After content validity, this amount was
reduced to 25 items. The exploratory factor analysis revealed four factors (self and other cons, coping and social
pros) containing 21 items that jointly accounted for 55.24% of the observed variance. The confirmatory factor
analysis indicated a model with appropriate fitness for the data. Cronbach’s alpha coefficient for the dimensions
ranged from .74 to .87, and the Intraclass Correlation Coefficient (ICC) ranged from .83 to .91, which is within
acceptable ranges.
Conclusion: The findings showed that the Methamphetamine Decisional Balance Scale is a valid and reliable scale
that increases our ability to study motivational factors related to MA use among young adult. Consequently, the
instrument could be applied in both practice and future studies.
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Background
Based on a report from the World Health Organization,
drug addiction is a chronic and frequent disorder that
threatens public health and society’s well-being world-
wide [1]. Methamphetamine (MA) is a highly addictive
stimulant and one of the most commonly used illicit
drugs in the world [2]. Particularly, MA use by young
adults is a serious social concern. National data in the
United States show that the prevalence of MA use
among individuals aged 12 or older increased from
353,000 in 2010 to 569,000 in 2014 [3] in spite of its
being illegal.
MA abuse leads to serious adverse health conse-
quences, including widespread sleep deficiency, phobias,
and poor health [4]. Moreover, in general, efficacious
medications for treating MA misuse are not available
[5–7]. Although any level of MA use for youths is illegal,
extreme consumption results in an increased risk of
serious negative sequelae such as accidents, unprotected
sex, and interpersonal violence [8, 9].
According to the Iranian Drug Control Headquarters
(DCHQ), 5.39% of people aged 15 to 64 in Iran are drug
users [10]. Furthermore, there is evidence of a growing
rate of MA use in Iran [11]. The most mentioned
reasons for the growth of MA use in Iran are its easy
accessibility, curiosity about having new experiences, low
price compared to other drugs, lack of awareness of its
complications, and expectations of improved sexual
performance [12]. Consequently, some young adults
believe that MA use has more benefits than side effects.
A better understanding of the benefits and side effects of
consuming MA may be helpful for programs that aim to
prevent substance abuse among adolescents [13–15].
Considering the high prevalence of MA dependence,
supporting a person’s motivation to change is the main
aim of prevention programs. A key construct associated
with someone’s motivation to change is decisional
balance (DB), which was developed based on the conflict
theory of decisions by Janis and Mann [16]. Both authors
assumed that decision making about a specific behavior
is based on the person’s consideration of possible gains
and losses. The pros and cons of DB are generally used
in the field of addiction treatment [17]. Based on the
Janis and Mann framework, there are four content struc-
tures of pros and cons that are usually considered in this
process: (a) losses/gains for oneself, (b) losses/gains for
significant others, (c) self-approval or -disapproval, and
(d) approval or disapproval from significant others. DB
is regularly categorized into two groups of pros and
cons, which may be anchored to either keeping or varying
a target behavior.
DB has also been linked to the transtheoretical model
(TTM), which refers to changes in behavior and its
causal motivation [17]. The TTM is an integrative model
that measures a person’s readiness to adopt different,
healthier behaviors and prepares approaches to guide
the individual in making these changes. The TTM
considers behavior modification to be a process that
develops over time, including progress via five stages of
change: pre-contemplation, contemplation, preparation,
action, and maintenance. Pros and cons not only make
evidence available about the positive and negative beliefs
toward a behavior but may also function as indicators
for preparation to change [18]. Certainly, persons who
progress further through the stages of change desire to
report more pros and fewer cons of change as well as
more cons and fewer pros of risky behavior. These
trends appear with a range of risky behaviors [19], such
as cigarette smoking among young adults [20]. However,
there is no formal DB instrument specific to MA at
this time.
Pros and cons are constructs similar to those in other
cognitive-motivational dimensions such as expectancies
and motives. Although DB instruments for tobacco use
have been developed [21, 22], instruments for assessing
motives for MA use do not exist. Furthermore, although
motives may equate to the pros of DB, motivational
evaluations do not address the perceived costs or
adverse aspects of MA use, which is a key element that
has been identified to be predictive of behavior change
[22]. On the other hand, the outcome expectancies for
MA consumption may also be associated with pros and
cons [23]. Expectancies display overall cognitions about
the probable consequences of intake behavior, while pros
and cons report motivational elements specific to a
person’s decisions about future behavior.
Given the existing theoretical dissimilarities, the devel-
opment of a DB instrument for MA may be ideally
suited to identify patterns of MA use. Pros refer to the
benefit of doing a behavior and can increase the interest
and intention of doing a behavior, while cons refer to
the barriers to doing behaviors and the negative effects
involved with doing those behaviors. Cons can decrease
one’s interest in doing a behavior like MA. In other
words, the pros and cons for using MA will refer to
what increases or decreases the interest in using MA,
thus providing information about what features of MA
are observed as interesting versus aversive in young
adults. For example, young adults may consider greater
relaxation due to MA use as an initiator, or pro, and
character changes as a disincentive, or con. However, no
validated instrument to measure the pros and cons has
yet been developed regarding MA use. Therefore, the
aim of the present study was to develop and test the
psychometric properties of a newly developed scale
called the METH-DBS. The scale can be used to explore
the pros and cons influencing Iranian young adults’ MA
use and potentially reveal areas to apply interventions to
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prevent MA use among young adults. To establish the
validity of METH-DBS, the relationship between the
scale scores will be associated with the scores of four
potentially associated constructs, namely, self-cons,
coping pros, social pros, and other cons.
Methods
Research design
The present study was approved by the Ethics Commit-
tee of Zanjan University of Medical Sciences, and in-
formed written consent was obtained from all
participants. All participants were students of the Zanjan
University of Medical Sciences in Zanjan, Iran. We
performed this study in two phases. In the first phase,
items were generated to develop the scale (in Farsi). A
qualitative study was performed to create the primary
suggestions for potential items regarding the perceived
pros and cons of MA use. After determining the most
suitable phrasing for each item, face and content validity
were assessed.
In the second phase, the items were administered from
a new sample. First, an exploratory factor analysis (EFA)
was performed to find the principal factor structure, and
items with insufficient loadings were removed. Then,
confirmatory factor analysis (CFA) of the measurement
model was applied in order to assess the coherence
between the data and the structure. Thereafter, the final
instrument was administered from an independent
sample to check its factor structure. Furthermore, the
convergent and discriminant validity and the internal
consistency of the new scale were calculated. Afterward,
test-retest reliability was assessed by means of an inde-
pendent sample of 30 students.
Phase 1: Item generation and instrument development
phase
A qualitative study was conducted to develop a scale for
assessing the pros and cons of MA use in young adults.
Three focus group discussions (FGDs) among 24 young
adults (8 participants per focus group) and 17 semi-
structured interviews were conducted with a focus on
the pros and cons of MA consumption based on DB
constructs of the TTM. The students were recruited
from October through December 2016.
A two-stage strategy was used to reach the partici-
pants. In the first stage, a total of 24 young adults
(M age = 23.92, SD = 2.62, 13 males) were recruited
from the schools of pharmacy, health, dentistry, nurs-
ing, and medicine that are affiliated with the Zanjan
University of Medical Sciences. Attempts were made
to reach students with varied demographic back-
ground characteristics. The researchers recruited par-
ticipants via email. Respondents could sign up for the
interviews by sending a message to the researchers.
Written informed consent was obtained, and the par-
ticipants were informed that the provided information
would be kept private and confidential.
During the FGDs, the participants first completed
questions on (a) sociodemographic (age, gender, year in
university, occupational status, educational level, marital
status, fields of study) and (b) their non-prescription use
of legal and illegal drugs both in the last months and
over the course of their lives. Then, students were
questioned about the pros and cons of MA consumption
related to their own experiences or, in case they had no
experience, their observations of others’ experiences. Fi-
nally, based on Janis and Mann’s (1977) framework, they
were encouraged to discuss personal losses/gains from
MA consumption, others’ losses/gains, self-approval and
-disapproval, and approval and disapproval from others
[16]. The sessions were facilitated by defining addiction
and using a semi-structured interview that started with
an open-ended question: “What are the pros and cons of
MA use for young adults?” Then, based on the partici-
pants’ answers, questions were generated to have a
discussion. Analytic ideas were recorded by memo
writing. The FGDs also allowed the researchers to find
potential respondents for the individual interviews.
In a second stage, students from the same schools
were recruited to participate in semi-structured inter-
views, with a maximum duration of 90 min. Among the
24 participants from the FGDs, seven mentioned during
the FGDs that they had used MA. These participants
were requested to supply additional data through indi-
vidual interviews. Then, 10 additional students were
recruited from different age groups, from different so-
cioeconomic backgrounds, and with varying educational
levels. The recruiters tried to reach participants living in
different situations at the time of the interviews, with
most participants living in dormitories and the others
living with their families. Among the 10 students, three
mentioned MA use. Of all MA users, their first experi-
ence with MA started at about age 21 (SD = 1.73, range:
19–24), and they described using MA for an average of
5 days (SD = 7.84) in the last 10 months. During the
interviews, participants were questioned about their
personal experiences of the pros and cons and also ques-
tioned using organized prompts concerning the possible
factors of pros and cons (e.g., health, social, academic).
This information was used to construct the phrasing of
the items.
Data analysis
Inductive thematic qualitative content analysis (a
bottom-up method to explore the data) was employed
based on the Braun and Clarke method in order to
converge and compare themes among participant data.
Themes were clustered according to participants’ views
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and experiences about the cons and pros of MA. Using
this method, we recognize themes based on the primary
codes and categories. As such, the units of analysis are
the entire interviews [24]. Data analysis started during
the data gathering. Each FGD and individual interview
was transcribed literally and analyzed before the next
FGD or interview was accomplished. Thorough under-
standing of the data was reached by frequently reading
the transcriptions.
The lists of pros and cons were generated with rate
counts (available from the first author upon request).
Answers that occurred many times or that converged on
a theme were maintained as items. Answers that were
unclear (e.g., “I had pleasure using it”), vague (e.g., “I
think it’s worth for your senses”), or not eligible as cons/
pros (e.g., “There are no dues on it”) were excluded.
Finally, items that were only mentioned once were also
omitted.
As mentioned above, the first draft of the scale was de-
veloped on the basis of the findings of the FGDs and the
individual interviews. The pre-final draft of the Metham-
phetamine Decisional Balance Scale (METH-DBS) for
young adults contained 40 items (in Farsi) that could be
answered on a 5-point response scale (1 = not at all im-
portant; 5 = very important) for maximizing variability
within the answers and measuring the importance of
each statement for participants’ decision to use MA. All
items were reread and revised for simplicity and wordi-
ness. Items were phrased as statements about the
positive and negative features of MA use. Then, content
and face validity were tested to develop the pre-final
version of the scale.
Content validity We applied qualitative and quantita-
tive content validity for METH-DBS. An expert panel
that consisted of a group of researchers who specialized
in drug addiction and psychometrics evaluated the con-
tent validity of the METH-DBS. In the qualitative phase,
the instrument was assessed in terms of wording, item
allocation, grammar, and scaling. Furthermore, the
content validity index (CVI) and the content validity ra-
tio (CVR) were tested in the quantitative phase. Clarity,
simplicity, and relevance of the items were measured by
a CVI assessment [25, 26]. A Likert-type ordinal scale
with four possible responses was used for measuring the
CVI. The responses were rated from 1 = not relevant,
not simple, and not clear to 4 = very relevant, very
simple, and very clear. The CVI was measured as the
proportion of items that acquired a rating of 3 or 4 by
the experts [27]. A CVI score of more than .80 for each
item was acceptable [28]. Furthermore, the essentiality
of each item was measured by the CVR. Each item was
scored by experts as 1 = essential, 2 = useful but not
essential, or 3 = not essential for measuring the CVR
[27]. According to the Lawshe Table [29], each item with
a CVR > .62 was considered to be satisfactory and was
kept.
In the quantitative phase, items with a CVR more than
.62 and a CVI more than .80 were accepted. Overall, 11
items were removed, resulting in a 29-item pool. Fur-
thermore, the experts reviewed the scale regarding
wording, grammar, and item allocation. The 29-item
pool remained in the analyses below and contained
either a positive belief (pro) or a negative belief (con)
that might occur to an individual who is deciding
whether to use MA or to start. Each item could be
answered on a 5-point scale: 1 = not important at
all, 2 = slightly important, 3 = moderately important,
4 = very important, 5 = extremely important.
Face validity Both qualitative and quantitative methods
were used to measure the face validity of the
METH-DBS. In the qualitative phase, 10 young adults
were asked to assess each item of the METH-DBS and
to indicate if they felt it was difficult or ambiguous to
answer the items. Based on the participants’ viewpoints,
the vague items were revised. In the quantitative stage,
the impact score (frequency × importance) was
measured to indicate the percentage of students who
recognized items as important or quite important on
a 5-point Likert scale. Consistent with other studies
[25, 30, 31], items were found to be suitable if they
had an impact score equal to or greater than 1.5
(which equates to a frequency of 50% or greater and
a mean importance of 3 on the 5-point Likert scale)
[32]. Overall, four items had an impact score equal to
or lower than 1.5, and 25 items had an impact score
ranging from 1.8 to 5. As such, the first form of the
instrument contained 25 items.
Phase 2: Psychometric evaluation of the methamphetamine
decisional balance scale (METH-DBS) for young adults
In order to test the psychometric properties of the
METH-DBS in a wider setting, a cross-sectional study
was carried out in Zanjan, Iran, from February 2017 to
April 2017. The participants were university students
from the schools of pharmacy, health, dentistry, nursing,
and medicine at Zanjan University of Medical Sciences.
A multistage random sampling method was used based
on sex ratio, educational levels, and field of study. Eight
hundred students who were at least 19 years old were
contacted based on phone numbers and emails provided
by the Education Department. Participants were contacted
irrespective of their MA use experiences. After the study
objectives were explained via telephone and email, 250
students agreed to participate. Table 1 provides the partic-
ipants’ descriptive characteristics.
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After the main investigator had a short interview with
each participant and provided information about the aim
of the study, students who agreed to participate com-
pleted the METH-DBS. Besides the METH-DBS, demo-
graphic questions about the participants were included
regarding age, level of education, fields of study, occupa-
tional status, marital status, and gender. Furthermore,
respondents were questioned as to whether they had
experiences of MA use as well as how old they were at
their first experience. Trained investigators performed
face-to-face interviews for data collection.
Measures
Due to the lack of suitable Iranian validated question-
naires about MA use, the Decisional Balance Inventory
(DBI) Adolescent Form for Smoking was used to estab-
lish the validity of the METH-DBS [33].
The DBI is a self-report scale that emphasizes either a
positive thought (pro) or a negative thought (con) that
might occur to an individual who is deciding whether to
smoke. The original DBI developed by Velicer (1998)
included 24 items that measured the opinions of adoles-
cents about the harms and benefits of smoking [22]. The






sample (n = 30)
Number (%) Number (%) Number (%)
Age (years)
19–24 103 (41.2) 105 (55.56) 8 (26.67)
25–29 126 (50.4) 68 (35.98) 17 (56.67)
30 and above 31 (12.4) 16 (8.46) 5 (16.66)
Mean (SD) 23.62 (2.74) 24.46 (3.1) 26.12 (3.24)
Range 19–32 20–32 23–32
Gender
Female 127 (50.8) 127 (67.2) 11 (36.66)
Male 123 (49.2) 62 (32.8) 19 (63.33)
Occupational status
Unemployed 215 (86) 165 (87.3) 21 (70)
Employed 35 (14) 24 (12.7) 9 (30)
Educational Level
Bachelor 47 (18.8) 32 (16.93) 8 (26.7)
Master degree 54 (21.6) 36 (19.05) 7 (23.3)
Doctorate 149 (59.6) 121 (64.02) 15 (50)
Marital status
Single/divorced/widowed 171 (68.4) 147 (77.8) 21 (70)
Married 79 (31.6) 42 (22.2) 9 (30)
Fields of study
Health 43 (17.2) 43 (22.75) 6 (20)
Dentistry 58 (23.2) 31 (16.4) 5 (16.7)
Nursing 44 (17.6) 33 (17.46) 7 (23.3)
Medicine 61 (24.4) 39 (20.63) 6 (20)
Pharmacy 44 (17.6) 43 (22.76) 6 (20)
Having experience of MA use
Yes 9 (3.6) 5 (2.64) 1 (3.3)
No 241 (96.4) 184 (97.36) 29 (96.7)
Age of first experience of MA
19–24 5 (55.56) 3 (60) 1 (100)
25–29 3 (33.33) 1 (20) 0
30 and above 1 (11.11) 1 (20) 0
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brief DBI developed by Pallonen (1998) consists of 12
items [33]. The shortened DBI measures one of the main
constructs of the TTM and contains three dimensions,
i.e., cons of smoking (six items), social pros (three
items), and coping pros (three items), and each item
ranged on a 5-point Likert-type scale (1 = not important
to 5 = extremely important). So, the minimum score is
12 and the maximum is 60. The DBI has proven to have
good validity and reliability in the Iranian population
[30]. In the present study, Cronbach’s alpha was .82,
indicating acceptable reliability.
Statistical analysis
Several statistical methods were performed to evaluate
the psychometric properties of the METH-DBS. They
are presented as follows.
Validity
Construct validity
After the item analysis, the 25 remaining items were
used to assess construct validity using both EFA and
CFA. Additionally, both convergent validity and diver-
gent validity were assessed.
Exploratory factor analysis EFA was applied to identify
the main factors of the METH-DBS. According to the
number of items in the METH-DBS, which was multi-
plied by 5–10 as suggested by [34, 35], the sample size
was assessed. The preferred maximum required sample
size was thus determined to be 250 young adults. These
participants were recruited from the different schools of
Zanjan University of Medical Sciences, including
pharmacy, health, dentistry, nursing, and medicine (see
data collection section). A principal component analysis
(PCA) with varimax rotation was applied to extract the
main factors. The Kaiser-Meyer-Olkin (KMO) test and
Bartlett’s test of sphericity were applied to evaluate the
adequacy of the sample for the factor analysis [36]. Any
factor with an eigenvalue of more than 1 was considered
acceptable for factor extraction, and a scree plot was
performed to specify the number of factors. Factor
loadings equal to or greater than .40 were considered
acceptable [37].
Confirmatory factor analysis A CFA was applied to as-
sess the coherence between the data and the structure.
Considering possible attrition related to test-retest ana-
lysis, we planned to recruit a separate sample of 189 uni-
versity students from the schools of pharmacy, health,
dentistry, nursing, and medicine affiliated with the
Zanjan University of Medical Sciences. Assigning 5–10
persons to each item, a sample size of 189 (9 × 21 = 189)
was estimated [25, 35]. The model fit was evaluated
using multiple fit indices. As recommended, various fit
indices measuring relative chi-square, root mean
square error of approximation (RMSEA), goodness of
fit index (GFI), comparative fit index (CFI), normed
fit index (NFI), non-normed fit index (NNFI), and
standardized root mean square residual (SRMR) were
taken into account [38]. The GFI, CFI, NFI, and
NNFI ranged between 0 and 1 [39], but values of .90
or above are commonly considered satisfactory model
fits [38]. An RMSEA value range from .08 to .10
indicates an average fit. Values below .05 represent a
good fit for SRMR, but values between .05 and .08
and between .08 and .10 indicate a close fit or are
satisfactory, respectively [40].
Convergent and divergent validity To assess conver-
gent and divergent validity, the 189 university students
completed the Iranian validated version of the DBI [30].
Initially, we measured item-convergent validity by exam-
ining the correlations between the item scores and the
subscale scores of the METH-DBS using the Spearman
correlation coefficient. We expected that, for each sub-
scale of the METH-DBS, the item scores of the subscale
(e.g., con) would correlate more with the total score of
the respective subscale (e.g., con) rather than the total
score of the subscales (e.g., pro). Correlation values ran-
ging from 0 to .20 are considered poor; from .21 to .40,
fair; from .41 to .60, good; from 0.61 to 0.80, very good;
and more than .81, excellent [41]. Item-convergent valid-
ity is achieved when each item has considerably greater
correlation with its own instrument compared with the
other instruments, and item divergent validity is
achieved when each item has less correlation with other
instruments [42]. Then we evaluated the convergent and
divergent validity of four subscales of the METH-DBS
(self-cons, other cons, coping pros, and social pros)
compared to the abovementioned validated inventory
(DBI) [30]. Convergent validity is confirmed when a sub-
scale of the METH-DBS correlates moderately with the
DBI (correlation .21 or more). We expected moderate cor-
relations between the pro subscale of the METH-DBS and
the pro subscale of the DBI as well as between the con
subscale of the METH-DBS and the con subscale of the
DBI. A poor correlation was found between a subscale of
the METH-DBS and the DBI.
Reliability
Internal consistency
Cronbach’s alpha coefficient was used to measure the
internal consistency of each item, the whole scale, and
each subscale (self cons, other cons, coping pros, and
social pros) of the METH-DBS. Alpha values of .70 or
above were considered acceptable [43].
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Test-retest reliability
Test-retest reliability was used to test the METH-DBS’s
stability by assessing the intraclass correlation coefficient
(ICC). Fifty university students were emailed and asked
to participate, of which 30 students agreed to participate.
The METH-DBS was re-administered to these students
2 weeks after the first completion. ICC values of .40 or
above are considered acceptable [44]. All statistical
analyses, except CFA, were applied using SPSS 22.0 [45].
The CFA was performed using AMOS version 22 of
SPSS [46].
Results
A total of 250 university students participated in the EFA
phase. The age of the respondents ranged from 19 to 29
(M age = 23.62, SD = 2.74). More than half (50.8%, n = 127)
of the participants were female, 31.6% (n = 79) were mar-
ried, and 59.6% (n = 149) had a doctorate. About 23.2%
(n = 58) of them studied dentistry, and 86% (n = 215) of
them were unemployed. Nearly 96.5% (n = 241) of the
participants had no experience of MA use. Table 1
provides the participants’ descriptive characteristics in
three analyses—EFA, CFA, and test-retest.
Construct validity
Exploratory factor analysis
The KMO measure was .733, and Bartlett’s test of spher-
icity was significant (χ2 = 2096.18, p < .001), demonstrat-
ing the adequacy of the sample for EFA. At the beginning,
for the 25-item scale, eight factors revealed eigenvalues
greater than 1, explaining the 68.55% variance, but the
scree plot revealed a 4-factor solution (Fig. 1). This
4-factor solution was explored by measuring item per-
formance with deletion of the items in a step-by-step
process. Using a varimax rotation, items were kept if
they loaded .40 or above on one factor. Four items
that did not meet the factor loading criteria were re-
moved. Thereafter, item loadings were again tested
and a final factor solution that consisted of a 21-item
scale loading on four distinct constructs was obtained.
The four factors were different from each other, both
statistically and theoretically, and jointly accounted
for 55.24% of the observed variance.
As shown in Table 2, four factors were found: factor 1
(self cons) included 7 items (items 1, 2, 3, 4, 5, 6, and 7),
factor 2 (coping pros) included 6 items (items 16, 17, 18,
19, 20, and 21), factor 3 (social pros) included 4 items
(items 10, 11, 12, and 13), and factor 4 (other cons) in-
cluded 4 items (items 8, 9, 14, and 15). See Appendix 1
for the items of the METH-DBS .
Confirmatory factor analysis (CFA)
A CFA was conducted on the 21-item scale to test the
fitness of the model obtained from the EFA. The best
model fit was obtained by applying covariance matrixes
and measuring fit indices. As shown in Fig. 2, all fit indi-
ces were satisfactory. The relative chi-square (χ2/df ) was
equal to 3.51 (p < .001). The RMSEA of the model was
.079 (90% CI = .061–.1), and the SRMR was .05. All com-
parative indices of the model, including GFI, CFI, NNFI,
and NFI, were more than .70 (.80, .81, .79, and .75,
respectively).
Convergent-divergent and concurrent validity
Table 3 presents the item-convergent validity for the
METH-DBS. As can be seen, all coefficients are higher
than .60, and most of them are higher than .70. Social
pros and self-cons had the highest and the lowest item--
convergent validity, respectively. Convergent validity
was assessed by the correlation between the four sub-
scales of the METH-DBS and the subscales of the
DBI. The correlation between the self and others cons
of the METH-DBS and the cons of the DBI was .736
and .690, respectively, which indicated that the
convergent validity was very good. Similarly, the
correlations between the social and coping pros of
the METH-DBS and the social and coping pros of
DBI were .576 and .688, respectively, demonstrating
an acceptable convergent validity. Based on Table 4,
the other correlations were low (≤ .20), indicating an
appropriate divergent validity (Table 4).
Reliability
In order to measure reliability, Cronbach’s alpha was
calculated separately for the METH-DBS as a whole and
for each dimension of the METH-DBS. Cronbach’s alpha
coefficient for the METH-DBS was .933 and ranged
from .736 to .871 for its subscales, which is well above
the acceptable threshold. Consequently, no items of the
questionnaire were deleted in this phase. In addition,
test-retest analysis was conducted to test the stability of
the instrument. The results indicated satisfactory
reliability. The ICC was .957 for the METH-DBS and
ranged from .832 to .907 for its subscales, lending
support for the stability of the questionnaire. The results
are presented in Table 5.
Discussion
In this study, we developed a decisional balance scale to
measure the costs and benefits of MA use (METH-DBS)
among young adults. This is the first study to provide a
measure for evaluating the items associated with the
costs and benefits of MA use in Iranian young adults.
The content of the scale items was first developed based
on a qualitative study to ensure that this scale covered
all theoretical concepts related to the costs and benefits
of MA use. After EFA, a four-domain scale emerged. A
CFA showed that the fit of the data was acceptable. As
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Table 2 Exploratory factory analysis of the METH-DBS (n = 250)
Item Factor 1 Factor 2 Factor 3 Factor 4
6. It damages my judgment, which may threaten myself or others. .769 −.004 .165 −.010
5. It conflicts with my functioning at home and/or at work. .754 .064 .184 −.084
1. It’s illegal, and I will have to worry about getting arrested. .729 .113 .054 .287
2. It could have unpleasant psychological effects (e.g., paranoia, hallucinations,
memory loss, and mood disturbances).
.718 .125 .092 .251
3. It might be harmful to my body (e.g., brain, liver, heart). .704 .023 .239 −.018
7. It causes me to feel more disobedient or unconventional. .692 .104 −.156 .209
4. It could intensify as a “gateway drug,” leading to other hazardous drug use. .586 .120 .360 .022
19. It will increase and improve my sex. .034 .755 −.059 .102
20. It will help me to centralize and be more creative. −.045 .713 −.210 .074
18. It could make me more relaxed or provide comfortable sleep. .068 .700 .001 −.022
21. It helps me to cope better with disappointment. .118 .664 −.192 .041
16. It will relieve tension, worry, fear, or anxiety. .128 .652 .096 −.259
17. It is something entertaining and breathtaking to do, especially if I’m tired. .099 .541 .189 −.166
13 Using methamphetamine would make others respect me more. .083 −.055 .786 .179
12. Using methamphetamine will make others understand me more positively
(e.g., calm, fun, friendly).
.120 −.036 .752 .119
10. It will provide chances for social activities (e.g., meeting new friends,
grouping, spending time with others).
.208 −.156 .595 −.121
11. It’s an escape from truth and daily life. .182 .023 .577 .059
8. It causes family members and/or coworkers to not respect me. .288 −.081 −.147 .752
9. It’s not approved of by the persons who are significant to me. .346 −.126 −.001 .738
15. It causes me to accidentally hurt others due to my daily use. −.006 −.031 .408 .659
14. It causes some persons close to me to become disappointed in me due to my daily use. −.097 .063 .373 .550
Note Figures in bold are related to factor loadings equal to or greater than 0.50
Fig. 1 Scree plot for determining the factors
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such, the final METH-DBS scale contained 21 items,
with 7 items representing self cons, 6 items representing
coping pros, 7 items representing social pros, and 4
items representing other cons of MA use. These results
are consistent with studies that developed DB constructs
for other health/risk behaviors [22]. Reliability analyses
indicated strong internal consistency (α > .90). As such,
we believe the METH-DBS scale represents a new scale
for understanding the motivations to use MA.
Items included in the self-cons subscales reflect
negative consequences of MA use on users that might
encourage/discourage persons to make decisions for
changing behavior. Items included in the other cons
subscales reflect the negative consequences of MA use
for significant others. The cons subscale about MA use
could help practitioners because it includes factors that
facilitate preventive behaviors about MA use, including
issues related to clients’ personal and social concerns.
Items included in the social pros subscale involve the
socially positive aspects of MA use from the users’ per-
spective. Additionally, the coping pros subscale includes
items that cover a wide range of reasons for using MA
to control people’s levels of tension and worry, usually
for the purpose of improving everyday activities. Pros
have a great impact on performing risky behaviors and
are associated with increasing MA use, so pros are of
great importance in the issue of behavioral change. It is
important to know that people who had more positive
expectations about ceasing use of MA or other risky be-
haviors felt more efficacious about performing behaviors
such as enhancing chances for social activities; being
calm; relieving tension, worry, and fear [18, 22, 47].
Changing risky behaviors, especially drug addiction
behaviors, requires long-term investments. Therefore, it
is unlikely for this group to agree to such behaviors out
of habit without any conscious decision to do so.
Fig. 2 A four-factor model for the questionnaire obtained from confirmatory factory analysis (n = 189)
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Several factors reinforced the pros of MA use, includ-
ing the increased rate of MA use, more problems that
led people to use MA for stress relief, and intentions to
use in the future, as well as stronger positive beliefs and
attitudes for legalizing MA. By showing the negative
effects and cons of MA use, use might decrease in
youngsters. Greater endorsement of cons was associated
with a decreased rate of use and fewer intentions to use
drugs, which is consistent with other studies displaying
an adverse relation between use rate and perceived risk
[48]. Participants who recognized cons held more beliefs
about negative consequences and were unlikely to favor
legalizing MA. However, cons were incoherently associ-
ated with MA-related problems. Similarly, in a study by
Noar et al. (2003) about alcohol DB, it was mentioned
that even clients experiencing few problems recognize
that there are cons to consuming MA [49]. The possibil-
ity for social interest bias was perceived for pros in one
sample, but there was no relationship with cons. There-
fore, participants who tried to present themselves in a
socially acceptable light were unwilling to admire the
pros of MA use, perhaps because it is an illegal drug.
The potential for social desirability bias should be
considered in future investigations using this scale.
The association between MA pros and cons across
stages of change provides cross-sectional support for
predictions from the TTM of change. Specifically, the
“crossover effect” appears to take place on the verge of
the preparation and action stages, which is late in the
phases based on some behaviors like safe sex, but it
estimates the point at which crossover happens for other
behaviors such as regular physical activity [22].
Generally, our findings indicated satisfactory psycho-
metric properties for the METH-DBS. The CVI and the
CVR showed that the content validity was acceptable.
Additionally, the findings support the construct validity
of the pros (coping and social) and cons (self and other)
dimensions, as the results of the EFA and CFA indicated
a good structure for our new instrument. EFA showed
that the four-factor structure of the scale accounted for
55.24% of the total observed variance. The cautious
selection of items for the instrument may be the reason
why we have attained such satisfactory results. In
addition, the CFA also displayed good fit indices for the
existing model, and the convergent validity of the
dimensions of the scale was good with a total score
between .61 and .88. Furthermore, the pros (coping and
social) and cons (self and other) in the final instrument
reveal several of the content domains mentioned by Janis
and Mann (1977) [16], counting personal gains/losses
from MA use (e.g., “It would relieve tension, worry, fear,
or anxiety”), gains/losses for others (e.g., “It causes me
to accidentally hurt others due to my daily use”), and
items about approval and disapproval from important
others (e.g., “It’s not approved of by persons who are sig-
nificant to me”). Based on item valence, many items
show agreement or disagreement. However, there was
no retained item that directly referenced self-approval or
disapproval.
The internal consistency of the final scale, as measured
by Cronbach’s alpha coefficient, was found to be .933,
Table 3 Item-scale correlation matrix for the four METH-DBS
measures (n = 189)
METH-DBS Dimensions SC CP SP OC
SC (item number)
Item 1 .608 .268 .396 .366
Item 2 .730 .438 .481 .480
Item 3 .812 .546 .538 .544
Item 4 .787 .443 .526 .518
Item 5 .749 .420 .459 .473
Item 6 .724 .464 .525 .599
Item 7 .690 .473 .512 .571
CP (item number)
Item 16 .331 .666 .422 .591
Item 17 .427 .783 .405 .548
Item 18 .358 .762 .525 .561
Item 19 .479 .833 .499 .551
Item 20 .597 .768 .528 .540
Item 21 .544 .717 .459 .528
SP (item number)
Item 10 .658 .576 .813 .667
Item 11 .600 .573 .880 .657
Item 12 .495 .452 .838 .592
Item 13 .546 .527 .865 .615
OC (item number)
Item 8 .564 .395 .568 .680
Item 9 .631 .531 .719 .765
Item 14 .502 .627 .503 .781
Item 15 .401 .617 .457 .743
Note. SC Self Cons, CP Coping Pros, SP Social Pros, OC Others Cons
The bold data reflect higher correlations for the four METH-DBS dimensions




Correlation with DBI Dimensions
Cons Social Pros Coping Pros
Self Cons .736 .688 .717
Others Cons .690 .535 .569
Social Pros .427 .576 .515
Coping Pros .453 .484 .688
Note. The bold data reflect higher correlations between the METH-DBS
domains and the three dimensions of the DBI
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which reflected acceptable reliability. Furthermore, the
ICC score showed suitable stability for the scale as it
was tested by 30 college students with a 2-week interval
(.957). As such, we believe that this newly generated
scale may be especially useful for health care teams to
understand and design approaches that are practical and
targeted to specific situations. The inclusion of four do-
mains in this scale further allows experts to know how
domains in which a person has needs can be boosted.
Limitations
Although the results of the present work confirmed
several benefits, some limitations must be addressed, as
with any other study. First, relating to the participants,
we only interviewed medical university students at a sin-
gle medical university in Zanjan, Iran, which possibly
limited the external validity of this scale. The young
adults of this sample are at high risk for MA use, and
both genders and several ethnicities are represented in
the sample. Although students vary both across and
within countries as much as the general public [50],
(medical) college students are however not representa-
tive of the general population. They are younger, higher
educated, keep different hours, have different habits and
may have different values. Given that some medical col-
lege students’ courses are related to drug related topics,
it seems that these students have more information
about the addiction and types of drugs. Consequently,
data gleaned from our sample cannot be generalized to
the viewpoint of university students studying in other
universities of Iran nor to the general population. Thus,
it might be interesting for future research to study the
reliability and validity of the METH-DBS in a sample of
young adults, with different backgrounds, and from
various regions. Second, we used two different samples
for our EFA and CFA. Although the same method was
performed to gather data from the participants, some
background information of the students was not the
same, particularly the experience of MA use, employ-
ment status, and field of study. This might have influ-
enced the results of the present study. Fourth, although
MA users were overrepresented compared to the popu-
lation prevalence, the inclusion of abstainers may have
led to the retaining of some items that would not have
been used by MA users and may be linked to the
large number of cons in the final instrument. Last,
generalizability to non-university-attending adults
cannot be expected; further investigation with other
populations must be performed before the instrument
is applied that would help to determine the usefulness
of the METH-DBS. Duplicating the factor structure with
different samples (e.g., those with MA dependence) could
shed light on its generalizability. Likewise, validating the
instrument with other participants would support its
usefulness beyond young adults who are attending a
university.
In summary, one of the objectives for the century is
preventing and controlling high-risk behavior such as
MA use [51]. To do so, we developed the METH-DBS,
which was demonstrated to have satisfactory psychomet-
ric properties. The METH-DBS measures pros and cons
of MA use that help to promote individuals’ health.
Conclusion
In general, the present findings show that the METH-DBS
is a valid and reliable instrument to assess the pros and
cons of MA use. Further studies with participants from
different backgrounds are suggested to find stronger
psychometric properties for the scale.
Appendix 1
Self Cons
1. It’s illegal, and I will have to worry about getting
arrested.
2. It could have unpleasant psychological effects (e.g.,
paranoia, hallucinations, memory loss, mood
disturbances).
3. It might be harmful to my body (e.g., brain, liver,
heart).
4. It could intensify as a “gateway drug,” leading to
other hazardous drug use.
5. It conflicts with my functioning at home and/or at
work.
6. It damages my judgment, which may threaten me or
others.
7. It makes me feel out of control.
Table 5 Measures of internal consistency and stability




1 Self Cons 7 items (1–7) 0.849 .907
2 Coping Pros 6 items (16–21) 0.842 .899
3 Social Pros 4 items (10–13) 0.871 .880
4 Others Cons 4 items (8, 9, 14, 15) 0.736 .832
Total 21 items 0.933 .957
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Other Cons
8. It causes family members and/or coworkers to not
respect me.
9. It’s not approved of by the persons who are
significant to me.
14. It causes some persons close to me to become
disappointed in me due to my daily use.
15. It causes me to accidentally hurt others due to my
daily use.
Social Pros
10. It will provide chances for social activities (e.g.,
meeting new friends, grouping, spending time
with others).
11. It’s an escape from truth and daily life.
12. Using methamphetamine will make others under-
stand me more positively (e.g., calm, fun, friendly).
13. Using methamphetamine would make others re-
spect me more.
Coping Pros
16. It will relieve tension, worry, fear, or anxiety.
17. It is something entertaining and breathtaking to
do, especially if I’m tired.
18. It could make me more relaxed or provide
comfortable sleep.
19. It will increase and improve my sex life.
20. It will help me to center myself and be more
creative.
21. It helps me to cope better with disappointment.
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